(Q46944814)

English

Intraarterial cisplatin/nedaplatin and intravenous 5-fluorouracil with concurrent radiation therapy for patients with high-risk uterine cervical cancer

scientific article published on 14 February 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16478629

Intraarterial cisplatin/nedaplatin and intravenous 5-fluorouracil with concurrent radiation therapy for patients with high-risk uterine cervical cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16478629

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

cervix uterine cancer

1 reference

based on heuristic

inferred from title

author name string

Setsuko Kawase

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16478629

Takahito Okuda

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16478629

Mitsuru Ikeda

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16478629

Shunichi Ishihara

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16478629

Yoshiyuki Itoh

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16478629

Shigeo Yanagawa

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16478629

Takeo Ishigaki

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16478629

language of work or name

0 references

publication date

14 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16478629

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16478629

102

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16478629

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16478629

493-499

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16478629

Results of treatment of early stage I carcinoma of the uterine cervix with intracavitary radium alone

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Randomized study of preoperative radiation and surgery or irradiation alone in the treatment of stage IB and IIA carcinoma of the uterine cervix: final report

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Therapeutic implications of patterns of recurrence in cancer of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group stud

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Intra-arterial chemotherapy with cisplatin followed by radical radiotherapy for locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Neoadjuvant intraarterial infusion chemotherapy in patients with stage IB2-IIIB cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Neoadjuvant chemotherapy by transcatheter arterial infusion method for uterine cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Clinical assessment by MRI for patients with stage II cervical carcinoma treated by radiation alone in multicenter analysis: are all patients with stage II disease suitable candidates for chemoradiotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Effect of balloon occluded arterial infusion of anticancer drugs on the prognosis of cervical cancer treated with radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Radiotherapy combined with transcatheter arterial infusion chemotherapy for locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Long-term result of high dose-rate afterloading brachytherapy in squamous cell carcinoma of the cervix: relationship between facility structure and outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Influence of Histologic Type and Age on Survival Rates for Invasive Cervical Carcinoma in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Nephrotoxicity of a new platinum compound, 254-S, evaluated with rat kidney cortical slices

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Minireview. The nephrotoxicity of cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Cisplatin nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Comparison of prognostic value of MRI and FIGO stage among patients with cervical carcinoma treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

Histologic types and prognosis of cancers of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.009

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YGYNO.2006.01.009

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16478629

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16478629

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46944814&oldid=2139360900"